Corporate News     16-Oct-23
Venus Remedies gets marketing approval for six key chemotherapy drugs from the Philippines
Venus Remedies has received marketing approval from the Philippines, the second largest ASEAN market, for six key chemotherapy drugs.

Venus Remedies has secured marketing authorisation for bortezomih cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines, thus making it a significant market for the company from the ASEAN region.

With this, Venus Remedies has secured 525 marketing approvals for its oneology products across 76 Countries.

Previous News
  Venus Remedies consolidated net profit declines 41.11% in the June 2022 quarter
 ( Results - Announcements 01-Aug-22   08:13 )
  Venus Remedies consolidated net profit declines 51.54% in the December 2021 quarter
 ( Results - Announcements 01-Feb-22   08:02 )
  Venus Remedies to announce Quarterly Result
 ( Corporate News - 26-Jul-22   19:02 )
  Venus Remedies AGM scheduled
 ( Corporate News - 24-Aug-24   10:36 )
  Venus Remedies edges higher after bagging supply order for oncology drugs from PAHO
 ( Hot Pursuit - 19-Jun-24   09:41 )
  Venus Remedies to conduct AGM
 ( Corporate News - 15-Jul-23   14:10 )
  Venus Remedies postpones board meeting
 ( Corporate News - 19-Jul-24   10:59 )
  Venus Remedies reports standalone net profit of Rs 2.01 crore in the June 2020 quarter
 ( Results - Announcements 16-Sep-20   07:50 )
  Oriental Trimex Ltd leads gainers in 'B' group
 ( Hot Pursuit - 23-Feb-23   12:15 )
  Venus Remedies consolidated net profit rises 493.91% in the June 2021 quarter
 ( Results - Announcements 13-Aug-21   08:45 )
  Venus Remedies standalone net profit rises 625.87% in the June 2021 quarter
 ( Results - Announcements 13-Aug-21   08:39 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top